Bill > HB2033

This bill, known as the Missouri Save Adolescents from Experimentation (SAFE) Act, prohibits healthcare providers from knowingly performing gender transition surgery on individuals under eighteen years of age. It also prohibits them from prescribing or administering cross-sex hormones, which are substances like testosterone or estrogen given in amounts greater than naturally occurring in a healthy individual of the same age and sex, or puberty-blocking drugs, which are medications used to delay or suppress pubertal development, for the purpose of gender transition in individuals under eighteen. However, these prohibitions on hormones and puberty blockers do not apply until March 1, 2027, to individuals under eighteen who were already receiving such treatments before August 28, 2023. Violating these provisions is considered unprofessional conduct, leading to license revocation, and also creates grounds for a civil lawsuit against the healthcare provider, with specific provisions for damages, attorney fees, and statute of limitations, though these provisions do not apply to speech protected by the First Amendment or to individuals with medically verifiable disorders of sex development, or in cases of imminent danger of death or impairment of a major bodily function.

Government Affairs

https://house.mo.gov/Bill.aspx?bill=HB2033&year=2026&code=R